BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26911803)

  • 1. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of eighth biannual meeting (September 2015).
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2016 Feb; 15():117. PubMed ID: 26911803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of seventh biannual meeting (March 2015).
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2015 Aug; 14():295. PubMed ID: 26242747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of sixth biannual meeting (September 2014).
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2015 Mar; 14():107. PubMed ID: 25881119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting.
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2013 Jun; 12():213. PubMed ID: 23787092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting.
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2012 Dec; 11():424. PubMed ID: 23253143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of fifth biannual meeting (March 2014).
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2014 Jul; 13():253. PubMed ID: 24992998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting.
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2013 Dec; 12():456. PubMed ID: 24359206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations.
    WHO Malaria Policy Advisory Committee and Secretariat
    Malar J; 2012 May; 11():137. PubMed ID: 22545931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening the policy setting process for global malaria control and elimination.
    D'Souza BJ; Newman RD
    Malar J; 2012 Jan; 11():28. PubMed ID: 22284049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria vaccine: WHO position paper, January 2016 - Recommendations.
    World Health Organization
    Vaccine; 2018 Jun; 36(25):3576-3577. PubMed ID: 28385607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria.
    Dondorp AM; Smithuis FM; Woodrow C; Seidlein LV
    Trends Parasitol; 2017 May; 33(5):353-363. PubMed ID: 28187990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The first international meeting of the Research Initiative on Traditional Antimalarial Methods (RITAM).
    Bodeker G; Willcox M
    J Altern Complement Med; 2000 Apr; 6(2):195-207. PubMed ID: 10784278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New treatment policy of malaria as a part of malaria control program in Indonesia.
    Kusriastuti R; Surya A
    Acta Med Indones; 2012 Jul; 44(3):265-9. PubMed ID: 22983085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of artemisinin resistance can only be met by eliminating Plasmodium falciparum malaria across the Greater Mekong subregion.
    Smith Gueye C; Newby G; Hwang J; Phillips AA; Whittaker M; MacArthur JR; Gosling RD; Feachem RG
    Malar J; 2014 Jul; 13():286. PubMed ID: 25064614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach.
    Canavati SE; Lawford HL; Fatunmbi BS; Lek D; Top-Samphor N; Leang R; Dondorp AM; Huy R; Kazadi WM
    Malar J; 2016 Feb; 15():120. PubMed ID: 26916933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How "resistant" is artemisinin resistant malaria? - The risks of ambiguity using the term "resistant" malaria.
    Hanscheid T; Hardisty DW
    Travel Med Infect Dis; 2018; 24():23-24. PubMed ID: 29715560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance.
    Wongsrichanalai C; Sibley CH
    Clin Microbiol Infect; 2013 Oct; 19(10):908-16. PubMed ID: 24033691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-malarial market and policy surveys in sub-Saharan Africa.
    Diap G; Amuasi J; Boakye I; Sevcsik AM; Pecoul B
    Malar J; 2010 Apr; 9 Suppl 1(Suppl 3):S1. PubMed ID: 20423536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artemisinin resistance--modelling the potential human and economic costs.
    Lubell Y; Dondorp A; Guérin PJ; Drake T; Meek S; Ashley E; Day NP; White NJ; White LJ
    Malar J; 2014 Nov; 13():452. PubMed ID: 25418416
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.